Kevin Bielamowicz
Pediatric Hematology-Oncology · Little Rock, ARNPI 1275707879
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 82.2% of it on its own, with 7 other manufacturers making up the rest.
Across 93 payments — averaging $1074.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$82K
- USWM, LLC$6K
- Springworks Therapeutics, Inc.$5K
- Genentech, Inc.$3K
- Y-mabs Therapeutics, Inc.$2K
- Beigene USA, Inc.$483
- plus $478 from 2 others
Across 27 payments — averaging $6846.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$84K
- Genentech, Inc.$58K
- Springworks Therapeutics, Inc.$33K
- Purdue Pharma L.p.$9K
What the payments were for
- Consulting fees$37,09337%
- Speaking & faculty fees$50,70051%
- Travel & lodging$9,88010%
- Food & beverage$2,0362%
- Education$2400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 78 | $82,132 |
| USWM, LLC | 2 | $6,300 |
| Springworks Therapeutics, Inc. | 2 | $5,254 |
| Genentech, Inc. | 7 | $3,002 |
| Y-mabs Therapeutics, Inc. | 1 | $2,300 |
| Beigene USA, Inc. | 1 | $483 |
| Vertex | 1 | $310 |
| Sobi, Inc | 1 | $168 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KOSELUGO$24,649
- Non-Covered Product$3,002
- DANYELZA$2,300
- Venclexta$1,637
- Gamifant$168
How this compares
Too few pediatric hematology-oncology providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 16 | $76 |
| Lorazepam | 20 | $36 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Little Rock
- Shelley CraryLittle Rock$64K
- Kimo StineLittle Rock$31K
- Michael BishopLittle Rock$10K
- Divyaswathi Citla SridharLittle Rock$3K
- Smitha Hosahalli VasannaLittle Rock$394
- Lauren AppellLittle Rock$292
- Jason FarrarLittle Rock$171
- Carolyn SaccenteLittle Rock$124
- Joana MackLittle Rock$90
- Medhavi HonharLittle Rock$42
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.